Oppenheimer & Co’s CapForce IBD 50 ETF FFTY Stock Holding History
Bought
Maintained
Sold
Other funds holding FFTY
CPIG
ACM
RJA
DADC
ASN
Oppenheimer & Co's FFTY Position: Q3 2021 in Review
Oppenheimer & Co sold out of CapForce IBD 50 ETF (FFTY) in Q3 2021, closing a stake of 5,700 shares — an estimated $264K sold.
Oppenheimer & Co first reported a position in FFTY in Q1 2018 and held it in 11 quarters. The position peaked at $692K in Q4 2018. 70 funds tracked by Wall St. Rank hold FFTY as of Q3 2021.
- Oppenheimer & Co reported no remaining CapForce IBD 50 ETF position as of Q3 2021 after selling out during the quarter.
- Oppenheimer & Co sold 5,700 CapForce IBD 50 ETF shares in Q3 2021, an estimated $264K.
- Oppenheimer & Co first reported a position in CapForce IBD 50 ETF in Q1 2018 and held it in 11 quarters.
- Oppenheimer & Co's CapForce IBD 50 ETF position peaked at $692K in Q4 2018.
- 70 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2021.
Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.